
FDA Warns of Blood Cancer Risk Linked to Sarcoma and Lymphoma Drug Tazemetostat (Tazverik); Manufacturer Pulls Drug From Market
The U.S. Food and Drug Administration (FDA) has issued a new safety alert about a serious risk linked to the cancer drug…










